Can notched P waves on an electrocardiogram (ECG) indicate Hypertrophic Cardiomyopathy (HCM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Notched P Waves Indicate Hypertrophic Cardiomyopathy?

Notched P waves can suggest HCM indirectly by indicating left atrial abnormality, which frequently accompanies left ventricular hypertrophy in HCM, but they are neither specific nor diagnostic for HCM itself. 1

Understanding the Relationship Between P-Wave Abnormalities and HCM

Notched P waves reflect left atrial abnormality rather than HCM directly. The mechanism involves:

  • Delayed left atrial activation causing separation of right and left atrial peaks that are normally fused, creating the characteristic double-peaked or notched appearance 1
  • Prolonged total atrial activation time (P-wave duration ≥120 ms) present in the majority of patients with left atrial abnormality 1, 2
  • Wide notching with ≥40 ms separation between peaks has equal diagnostic value to P-wave duration criteria 1, 2

The connection to HCM occurs because left atrial abnormalities frequently accompany left ventricular hypertrophy and may represent the earliest ECG sign of hypertensive heart disease or cardiomyopathy. 1

Critical Limitations as an HCM Indicator

P-wave abnormalities should only be used as a supporting criterion, not a diagnostic criterion for HCM or LVH. 1 Here's why:

  • Low specificity: Similar P-wave abnormalities occur frequently in the absence of LVH or HCM 1
  • Multiple etiologies: Atrial dilatation, muscular hypertrophy, elevated atrial pressure, impaired ventricular distensibility, and delayed intraatrial conduction all produce similar P-wave changes 1, 2
  • Inadequate clinical validation: Studies assessing the accuracy of P-wave criteria alone or combined with other criteria for diagnosing LVH have not been adequately reported 1

The ECG Profile in Confirmed HCM

When HCM is present, the ECG typically shows:

  • Variable combination of LVH, ST- and T-wave abnormalities, and pathological Q-waves in 94% of referral cohort patients 1
  • Normal ECG at presentation in approximately 6% of HCM patients 1, 3
  • Less than 25% of HCM patients detected by screening echocardiography have abnormal ECG findings (LVH or T-wave inversion) 3
  • Better prognosis in HCM patients with normal ECGs—none experienced cardiac death at follow-up in one study 4

Importantly, even with demonstrable echocardiographic evidence of HCM, the ECG may remain completely normal, indicating that ECG alone lacks sensitivity for HCM detection. 3, 4

Specific P-Wave Findings in HCM Populations

Research demonstrates that HCM patients have:

  • Longer P-wave duration compared to healthy controls (149 ± 22 ms vs 130 ± 16 ms) 5
  • Higher prevalence of interatrial conduction block of varying severity 5
  • Conduction pattern changes most prominent in orthogonal Leads Y and Z 5

These findings suggest that prolonged P-wave duration in HCM reflects a higher prevalence of block in interatrial conduction routes rather than being pathognomonic for the disease. 5

Clinical Approach When Notched P Waves Are Identified

When you encounter notched P waves, follow this algorithm:

  1. Measure P-wave duration: ≥120 ms suggests left atrial abnormality 1, 2
  2. Assess notch width: ≥40 ms between peaks is significant 1, 2
  3. Evaluate P terminal force in lead V1: Increased amplitude × duration of terminal negative component supports left atrial abnormality 1, 2
  4. Search for underlying cardiac conditions: Mitral valve disease, hypertension, heart failure, or cardiomyopathies 2
  5. Perform echocardiography: This is the primary imaging modality to assess left atrial size, left ventricular wall thickness, and exclude or confirm HCM 1, 2

Common Pitfalls to Avoid

  • Do not rely solely on P-wave morphology for diagnosing HCM—correlation with clinical findings and imaging is essential 2
  • Avoid outdated terminology like "P-mitrale" or "atrial hypertrophy"; use "left atrial abnormality" instead 1, 2
  • Do not overlook normal variants and technical factors that can affect P-wave appearance 2
  • Remember that interatrial conduction delay can cause bifid P waves even without atrial enlargement 2
  • Do not assume ECG sensitivity: Up to 23% of HCM patients may have normal 12-lead ECGs despite having abnormal electrophysiological properties detectable by advanced techniques 6

Risk Stratification Context

In established HCM, ambulatory ECG monitoring is recommended at initial assessment to evaluate sudden cardiac death risk and stroke risk, as asymptomatic non-sustained ventricular tachycardia occurs in 25% of adults with HCM and paroxysmal supraventricular arrhythmias in up to 38%. 1 The presence of P-wave abnormalities indicating left atrial abnormality may correlate with increased atrial fibrillation risk. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ECG Diagnosis of Left Atrial Abnormality

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.

Journal of the American College of Cardiology, 2009

Research

Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.